Biopharma Hiring, IP Clash, and HbF Discovery
Kilder
- GEN: Genome-Wide Analysis Identifies BACH2 as Potential Fetal Hemoglobin Activation Target
- Nature: Human genetics implicates a BACH2–NRF2 axis in fetal haemoglobin activation - Nature
- Medicalxpress: Possible new target for sickle cell disease and beta thalassemia treatment identified - medicalxpress.com
- STAT: STAT+: Three biotech updates, including accusations of theft and and a new lobbying leader
- STAT: Beam Therapeutics sues Chinese biotech, VC-backed startup, alleging theft of intellectual property - STAT
- BioSpace: The top 12 companies hiring in biopharma now
- BioSpace: Urgency, flexibility during Q4 job search among keys to success - BioSpace
- Endpoints: New biotech alliance tells Congress to fight for US dominance
- GEN: Advancing Brain Organoids from Research Models to Scalable Platforms
- Endpoints: AbbVie's eczema drug shows benefit in Phase 2; BioMarin lays off 117
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.